EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma

NCT01000285 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Leukemia-Lymphoma, Adult T-Cell

Interventions

DRUG: Bortezomib
DRUG: Etoposide
DRUG: Vincristine
DRUG: Doxorubicin
DRUG: Prednisone
DRUG: Cyclophosphamide
DRUG: Raltegravir

Sponsor

Washington University School of Medicine